Angelina Jolie Britain testing prevention patient drug Angelina Jolie Britain

New cancer drug breakthrough could treat diseases triggered by 'Angelina Jolie gene'

Reading now: 170
msn.com

A new type of drug could treat a range of cancers triggered by the 'Angelina Jolie gene,' according to a new study. British researchers have identified a new class of targeted cancer drugs that offer the potential to treat patients whose tumours have faulty copies of the BRCA cancer genes.

The drugs, known as POLQ inhibitors, specifically kill cancer cells with mutations in the BRCA genes while leaving healthy cells unharmed.

And crucially, they can kill cancer cells that have become resistant to PARP inhibitors - an existing treatment for patients with BRCA mutations.

Researchers are already planning to test the new drug class in upcoming clinical trials. If the trials are successful, POLQ inhibitors could enter the clinic as a new.

Read more on msn.com
The website celebsbar.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA